These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 17785089

  • 1. [Dysferlin expression in limb-girdle muscular dystrophy and Miyoshi myopathy: analysis of 45 cases].
    Ren SC, Yan CZ, Li MX, Liu SP, Wu JL, Zhao YY, Li W, Li DN.
    Zhonghua Yi Xue Za Zhi; 2007 Jun 05; 87(21):1486-90. PubMed ID: 17785089
    [Abstract] [Full Text] [Related]

  • 2. Dysferlinopathy: a clinical and histopathological study of 28 patients from India.
    Nalini A, Gayathri N.
    Neurol India; 2008 Jun 05; 56(3):379-85; discussion 386-7. PubMed ID: 18974568
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemistry of sarcolemmal membrane-associated proteins in formalin-fixed and paraffin-embedded skeletal muscle tissue: a promising tool for the diagnostic evaluation of common muscular dystrophies.
    Suriyonplengsaeng C, Dejthevaporn C, Khongkhatithum C, Sanpapant S, Tubthong N, Pinpradap K, Srinark N, Waisayarat J.
    Diagn Pathol; 2017 Feb 20; 12(1):19. PubMed ID: 28219397
    [Abstract] [Full Text] [Related]

  • 4. Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients.
    Tagawa K, Ogawa M, Kawabe K, Yamanaka G, Matsumura T, Goto K, Nonaka I, Nishino I, Hayashi YK.
    J Neurol Sci; 2003 Jul 15; 211(1-2):23-8. PubMed ID: 12767493
    [Abstract] [Full Text] [Related]

  • 5. Heterogeneous characteristics of Korean patients with dysferlinopathy.
    Park HJ, Hong JM, Suh GI, Shin HY, Kim SM, Sunwoo IN, Suh BC, Choi YC.
    J Korean Med Sci; 2012 Apr 15; 27(4):423-9. PubMed ID: 22468107
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dysferlin is a surface membrane-associated protein that is absent in Miyoshi myopathy.
    Matsuda C, Aoki M, Hayashi YK, Ho MF, Arahata K, Brown RH.
    Neurology; 1999 Sep 22; 53(5):1119-22. PubMed ID: 10496277
    [Abstract] [Full Text] [Related]

  • 9. New aspects on patients affected by dysferlin deficient muscular dystrophy.
    Klinge L, Aboumousa A, Eagle M, Hudson J, Sarkozy A, Vita G, Charlton R, Roberts M, Straub V, Barresi R, Lochmüller H, Bushby K.
    J Neurol Neurosurg Psychiatry; 2010 Sep 22; 81(9):946-53. PubMed ID: 19528035
    [Abstract] [Full Text] [Related]

  • 10. DYSF mutation analysis in a group of Chinese patients with dysferlinopathy.
    Zhao Z, Hu J, Sakiyama Y, Okamoto Y, Higuchi I, Li N, Shen H, Takashima H.
    Clin Neurol Neurosurg; 2013 Aug 22; 115(8):1234-7. PubMed ID: 23254335
    [Abstract] [Full Text] [Related]

  • 11. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes.
    Nguyen K, Bassez G, Krahn M, Bernard R, Laforêt P, Labelle V, Urtizberea JA, Figarella-Branger D, Romero N, Attarian S, Leturcq F, Pouget J, Lévy N, Eymard B.
    Arch Neurol; 2007 Aug 22; 64(8):1176-82. PubMed ID: 17698709
    [Abstract] [Full Text] [Related]

  • 12. Clinical, morphological and immunological evaluation of six patients with dysferlin deficiency.
    Prelle A, Sciacco M, Tancredi L, Fagiolari G, Comi GP, Ciscato P, Serafini M, Fortunato F, Zecca C, Gallanti A, Chiveri L, Bresolin N, Scarlato G, Moggio M.
    Acta Neuropathol; 2003 Jun 22; 105(6):537-42. PubMed ID: 12734659
    [Abstract] [Full Text] [Related]

  • 13. Calpain-3 and dysferlin protein screening in patients with limb-girdle dystrophy and myopathy.
    Fanin M, Pegoraro E, Matsuda-Asada C, Brown RH, Angelini C.
    Neurology; 2001 Mar 13; 56(5):660-5. PubMed ID: 11245721
    [Abstract] [Full Text] [Related]

  • 14. Expression of myoferlin in skeletal muscles of patients with dysferlinopathy.
    Inoue M, Wakayama Y, Kojima H, Shibuya S, Jimi T, Oniki H, Nishino I, Nonaka I.
    Tohoku J Exp Med; 2006 Jun 13; 209(2):109-16. PubMed ID: 16707852
    [Abstract] [Full Text] [Related]

  • 15. [Mutational and clinical features of Japanese patients with dysferlinopathy (Miyoshi myopathy and limb girdle muscular dystrophy type 2B)].
    Aoki M, Takahashi T.
    Rinsho Shinkeigaku; 2005 Nov 13; 45(11):938-42. PubMed ID: 16447768
    [Abstract] [Full Text] [Related]

  • 16. Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies).
    Anderson LV, Harrison RM, Pogue R, Vafiadaki E, Pollitt C, Davison K, Moss JA, Keers S, Pyle A, Shaw PJ, Mahjneh I, Argov Z, Greenberg CR, Wrogemann K, Bertorini T, Goebel HH, Beckmann JS, Bashir R, Bushby KM.
    Neuromuscul Disord; 2000 Dec 13; 10(8):553-9. PubMed ID: 11053681
    [Abstract] [Full Text] [Related]

  • 17. CD4+ cells, macrophages, MHC-I and C5b-9 involve the pathogenesis of dysferlinopathy.
    Yin X, Wang Q, Chen T, Niu J, Ban R, Liu J, Mao Y, Pu C.
    Int J Clin Exp Pathol; 2015 Dec 13; 8(3):3069-75. PubMed ID: 26045819
    [Abstract] [Full Text] [Related]

  • 18. [Positional cloning of the gene for Miyoshi myopathy and limb-girdle muscular dystrophy].
    Aoki M, Arahata K, Brown RH.
    Rinsho Shinkeigaku; 1999 Dec 13; 39(12):1272-5. PubMed ID: 10791095
    [Abstract] [Full Text] [Related]

  • 19. Dysferlin deficiency and the development of cardiomyopathy in a mouse model of limb-girdle muscular dystrophy 2B.
    Chase TH, Cox GA, Burzenski L, Foreman O, Shultz LD.
    Am J Pathol; 2009 Dec 13; 175(6):2299-308. PubMed ID: 19875504
    [Abstract] [Full Text] [Related]

  • 20. The clinical, myopathological, and molecular characteristics of 26 Chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants.
    Wang N, Han X, Hao S, Han J, Zhou X, Sun S, Tang J, Lu Y, Wu H, Ma S, Song X, Ji G.
    BMC Neurol; 2022 Nov 01; 22(1):398. PubMed ID: 36319958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.